Tag Archives: Investigational

Investigational ALS drug prolongs patient survival in clinical trial

nerve cell

Investigational ALS drug prolongs patient survival in clinical trial Investigational ALS drug prolongs patient survival in clinical trial Credit: CC0 Public Domain An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential …

Read More »

Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults

Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults

Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults Colorized scanning electron micrograph shows SARS-CoV-2 virus particles (yellow), isolated from a patient. Credit: NIAID A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown …

Read More »

Investigational ALS drug generates promising clinical trial results

Amyotrophic Lateral Sclerosis

Investigational ALS drug generates promising clinical trial results Investigational ALS drug generates promising clinical trial results An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/Wikipedia An experimental medication slows …

Read More »

FDA clears investigational new drug application for Calibr’s ‘switchable’ CAR-T therapy

Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr’s “switchable” CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such …

Read More »

Investigational drugs reduce risk of death from Ebola virus disease

The Ebola treatment center (ETC) in Beni, Democratic Republic of the Congo. Operated by The Alliance for International Medical Action (ALIMA), the Beni ETC enrolled patients in the PALM study of Ebola therapeutics. The ETC is now operated by MSF. Credit: ALIMA The investigational therapeutics mAb114 and REGN-EB3 offer patients …

Read More »